glp 1 for hidradenitis suppurativa GLP-1s Linked to Systemic Clinical Risk Reduction in 392: Improving Hidradenitis Suppurativa HS
Description
As patient access improves and awareness spreads, the demand for these therapies will increase, despite challenges like high treatment costs and market competition. - Shambhu Nath Jha, Principal Consultant at Fact MR
The authors highlighted their stepwise approach to insulin reduction, which involved prompt weekly insulin dose decreases of 1020% when preprandial or fasting glucose levels were consistently between 80 and 130 mg/dL
[DOI] [PubMed] [Google Scholar] 404.Huang Y., Wilkinson G.F., Willars G.B
The, Empa-Kidney Collaborative Group
